Skip to main content
ORKA logo

ORKA · Oruka Therapeutics, Inc.

$94.32 +2.61 (+2.85%) At close · Jul 21
Market Cap
$5.69B
Shares
60.31M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Lawrence Klein $3,356,050
Paul Quinlan $2,338,593
Joana Goncalves $2,338,593
Fiscal 2024
Executive Total
Thomas A. Keuer $853,520
C. Jeffrey Dekker $756,604
Lawrence Klein $520,911
Michael Bristow $510,416
Joana Goncalves $317,986
General Counsel $317,986
Paul Quinlan $310,445
Fiscal 2023
Executive Total
Thomas A. Keuer $400,802
Michael Bristow $358,800
C. Jeffrey Dekker $323,072
Fiscal 2022
Executive Total
Thomas A. Keuer $448,993
Michael Bristow $358,800
Christopher D. Ozeroff $316,429
Fiscal 2021
Executive Total
Michael Bristow $526,513
Thomas A. Keuer $420,615
Christopher D. Ozeroff $366,029
Former Secretary $366,029
Fiscal 2020
Executive Total
Michael Bristow $1,061,587
Thomas A. Keuer $631,024
Christopher D. Ozeroff $555,848
Fiscal 2019
Executive Total
Thomas A. Keuer $304,022
Michael Bristow $296,151
Christopher D. Ozeroff $290,157
Fiscal 2018
Executive Total
Thomas A. Keuer $326,786
Michael Bristow $320,490
Christopher D. Ozeroff $310,257
Key facts CIK 907654 CUSIP 687604108 13F (30d) 16 filings 16 filers Visit website Investor relations